SOX15 Transcriptionally Decreases the Level of MMP2 and Inhibits Vasculogenic Mimicry to Slow Down the Progression of Ovarian Cancer
Biology of the Cell · 2025
DOI: 10.1111/boc.70031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biology of the Cell, 2025. Verfasst von Xiaodan Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Diagnosis, The Second Hospital of Heilongjiang Province, Harbin, Heilongjiang, China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Matrix Metalloproteinase 2, Neovascularization, Pathologic, SOX Transcription Factors. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Scientific Research Project of Health Commission of Heilongjiang Province.
Abstract (Originalsprache)
Background
Information Vascular mimicry (VM) is pivotal for promoting tumor cell proliferation and invasion in ovarian (OV) cancer patients. Sex‐determining region Y‐box 15 (SOX15) suppresses the malignant growth of tumor cells. However, the function of SOX15 in OV cancer remains undefined. Using SKOV‐3 and ES2 cell lines, along with xenograft models in nude mice, we investigated the effects of SOX15 on tumor cell growth and VM formation in OV cancer, as well as the underlying mechanisms.
Results
We found that SOX15 inhibited the proliferation, migration, and invasion of SKOV‐3 cells. SOX15 overexpression reduced VM formation in SKOV‐3 cells, accompanied by decreased levels of VE‐cadherin and vascular endothelial growth factor A (VEGFA). Similarly, SOX15 suppressed ES2 cell proliferation and motility. Additionally, xenograft experiments demonstrated that SOX15 knockdown increased tumor volume in mice, along with upregulated expression of Ki67 and matrix metalloproteinase‐2 (MMP2) in tumor tissues. CD31/PAS double staining revealed that silencing SOX15 promoted VM formation in tumors. Mechanistically, SOX15 overexpression downregulated MMP2 at both mRNA and protein levels, suppressing VM formation and thereby slowing OV cancer progression. Dual‐luciferase reporter assays revealed that SOX15 overexpression inhibited MMP2 promoter activity, and chromatin immunoprecipitation followed by PCR (ChIP‐PCR) confirmed the direct binding of SOX15 to the MMP2 promoter.
Conclusions
Our results indicate that SOX15 transcriptionally represses MMP2 expression, thereby inhibiting VM formation and ultimately suppressing OV cancer initiation and progression. Significance We establish a theoretical foundation for developing novel therapeutic approaches targeting the SOX15/MMP2 axis in OV cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physical Diagnosis, The Second Hospital of Heilongjiang Province, Harbin, Heilongjiang, China.
- Department of Gynecology, The Second Hospital of Heilongjiang Province, Harbin, Heilongjiang, China.
ORCID-Profile: Xiaodan Zhao, Lihong Gong
Förderung
- Scientific Research Project of Health Commission of Heilongjiang Province
Zitieren
APA
Zhao, X., Wang, X., Wang, C., Tian, H., Zhou, Y., & Gong, L. (2025). SOX15 Transcriptionally Decreases the Level of MMP2 and Inhibits Vasculogenic Mimicry to Slow Down the Progression of Ovarian Cancer. Biology of the Cell. https://doi.org/10.1111/boc.70031
Vancouver
Zhao X, Wang X, Wang C, Tian H, Zhou Y, Gong L. SOX15 Transcriptionally Decreases the Level of MMP2 and Inhibits Vasculogenic Mimicry to Slow Down the Progression of Ovarian Cancer. Biology of the Cell. 2025. doi:10.1111/boc.70031
BibTeX
@article{Zhao2025,
author = {Zhao, Xiaodan and Wang, Xinjia and Wang, Chao and Tian, Huiyu and Zhou, Yang and Gong, Lihong},
title = {SOX15 Transcriptionally Decreases the Level of MMP2 and Inhibits Vasculogenic Mimicry to Slow Down the Progression of Ovarian Cancer},
journal = {Biology of the Cell},
year = {2025},
doi = {10.1111/boc.70031}
}
EUVIMED